Doha: Ebn Sina Pharmacy – a fully owned subsidiary of Aamal Company Q.P.S.C., one of the region’s fastest growing diversified companies – has celebrated the reopening of its pharmacy in City Center Doha Shopping Center after its complete renovation. Ebn Sina Pharmacy, which is fully managed by Ebn Sina Medical Company, has witnessed full renovation together with the introduction of a state-of-the-art Robot (“RIEDL PHASYS” – Pharmacy Automation System) installed by the Italian company GPI, whose products are exclusively represented by Ebn Sina Medical in Qatar.

Sheikh Faisal Bin Qassim Al Thani - Chairman of Aamal Company Q.P.S.C. - attended the opening ceremony, joined by all the Company’s employees.

The Robot is able to accommodate more than 12,000 packs of medicine, very accurately and quickly dispensing medications according to patients’ prescriptions and efficiently serving the pharmacy’s customers during busy periods.

Commenting on the re-opening, Sheikh Faisal Bin Qassim Al Thani said: “It is my pleasure to see the introduction of this new technology at Ebn Sina Pharmacy in City Center. This follows its complete renovation and the implementation of cutting-edge technology, with the installation of the first robot in Qatar’s private pharmacy sector. Aamal closely follows the latest developments in international automation and we are always keen to introduce the latest technologies to the Qatari market.  This is also a great opportunity to personally thank all our colleagues for their exceptional efforts and continuous commitment”.

Mr. Sherif Shehata - General Manager of Ebn Sina Medical – commented: “We are always looking to implement the latest technologies across all our operations, including our retail pharmacies, and we achieve this through partnering with international suppliers and market-leaders in the medical sector.

In 2019 our main objective is to maintain our market-leading position and our ongoing growth, and we look forward to continuing to address growing market demands and challenges by collaborating with leading pharmaceuticals and medical equipment companies”.

Ebn Sina Pharmacy in City Center started operating at the beginning of 2001, and it is one of the leading pharmacies in Doha, with a market-leading position amongst pharmacies in Qatar.

As well as Ebn Sina Pharmacy in City Center, Ebn Sina Pharmacy in Ras Abu-Aboud was successfully opened in July 2018 and there are plans to open a third state-of-the-art pharmacy at the Rail Project in Mushaireb Metro Station.


This announcement is not considered price-sensitive information. Referencing  Articles (47), (50), and (58) of QFMA’s Rulebook on Offering and Listing of Securities and QFMA’s instructions on the disclosure of significant non-financial information that has impact on the share price of a listed company, this corporate development doesn’t fall under the scope of the rules and regulations concerning disclosing non-financial price-sensitive information.

For further enquiries, please contact:

Aamal Company Q.P.S.C.:
+974 44350666
Laura Ackel – Marketing and Communications Officer

Aamal Company Q.P.S.C.:
Aamal is one of the region’s fastest growing diversified conglomerates and has been listed on the Qatar Stock Exchange since December 2007. As at 20 May 2019, the Company had a market capitalisation of QAR 5.0 bn (US$ 1.4 bn).

Aamal’s operations are widely diversified and comprise 26 active business units (subsidiaries and joint ventures) with market leading positions in the key industrial, retail, property, managed services, and medical equipment and pharmaceutical sectors, thereby offering investors a high quality and balanced exposure to Qatar’s wider economic growth and development. Aamal is focused on self-financed and profitable growth, delivering an average increase in underlying profits in excess of 11.1% (i.e. before fair value gains on investment properties) over the twelve years to end-2018.

For further information on Aamal Company, please refer to the corporate website:  

Ebn Sina Medical Company:
Ebn Sina Medical is the leading pharmaceutical distribution company in Qatar with exclusive distribution agreements with more than 60 multinational pharmaceutical companies. It is active in the importation, distribution, promotion and retailing of pharmaceuticals, appliances and disposables in addition to consumer products.

Ebn Sina Medical provides complete professional services to government departments, retail pharmacies, private clinics, industrial companies and all the local market.

Alongside this professional knowledge and expertise, Ebn Sina Medical conforms to all Qatar regulatory requirements. and has implemented frequently updated quality management systems. Ebn Sina Medical is a registered trademark in Qatar.

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.